Cargando…

HSP90 inhibitors potentiate PGF(2α)-induced IL-6 synthesis via p38 MAP kinase in osteoblasts

Heat shock protein 90 (HSP90) that is ubiquitously expressed in various tissues, is recognized to be a major molecular chaperone. We have previously reported that prostaglandin F(2α) (PGF(2α)), a potent bone remodeling mediator, stimulates the synthesis of interleukin-6 (IL-6) through p44/p42 mitoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kazuhiko, Tokuda, Haruhiko, Kuroyanagi, Gen, Yamamoto, Naohiro, Kainuma, Shingo, Kawabata, Tetsu, Sakai, Go, Matsushima-Nishiwaki, Rie, Kozawa, Osamu, Otsuka, Takanobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438147/ https://www.ncbi.nlm.nih.gov/pubmed/28542188 http://dx.doi.org/10.1371/journal.pone.0177878

Ejemplares similares

HSP22 (HSPB8) positively regulates PGF2α-induced synthesis of interleukin-6 and vascular endothelial growth factor in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2021)

Upregulation of TGF-β-induced HSP27 by HSP90 inhibitors in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2022)

Heat shock protein 27 (HSPB1) suppresses the PDGF-BB-induced migration of osteoblasts
por: Kainuma, Shingo, et al.
Publicado: (2017)

HSP70 Inhibitor Suppresses IGF-I-Stimulated Migration of Osteoblasts through p44/p42 MAP Kinase
por: Kawabata, Tetsu, et al.
Publicado: (2018)

Tramadol enhances PGF(2α)-stimulated osteoprotegerin synthesis in osteoblasts
por: Kim, Woo, et al.
Publicado: (2020)

HSP70 inhibitors upregulate prostaglandin E(1)-induced synthesis of interleukin-6 in osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2022)

(−)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity
por: Kawabata, Tetsu, et al.
Publicado: (2018)

Down-Regulation by Resveratrol of Basic Fibroblast Growth Factor-Stimulated Osteoprotegerin Synthesis through Suppression of Akt in Osteoblasts
por: Kuroyanagi, Gen, et al.
Publicado: (2014)

Incretin accelerates platelet-derived growth factor-BB-induced osteoblast migration via protein kinase A: The upregulation of p38 MAP kinase
por: Kawabata, Tetsu, et al.
Publicado: (2020)

Factor Xa Inhibitor Suppresses the Release of Phosphorylated HSP27 from Collagen-Stimulated Human Platelets: Inhibition of HSP27 Phosphorylation via p44/p42 MAP Kinase
por: Tsujimoto, Masanori, et al.
Publicado: (2016)

Thrombin Receptor-Activating Protein (TRAP)-Activated Akt Is Involved in the Release of Phosphorylated-HSP27 (HSPB1) from Platelets in DM Patients
por: Tokuda, Haruhiko, et al.
Publicado: (2016)

Involvement of AMP-activated protein kinase in TGF-β-stimulated VEGF synthesis in osteoblasts
por: MIZUTANI, JUN, et al.
Publicado: (2012)

(-)-Epigallocatechin Gallate Reduces Platelet-Derived Growth Factor-BB-Stimulated Interleukin-6 Synthesis in Osteoblasts: Suppression of SAPK/JNK
por: Takai, Shinji, et al.
Publicado: (2008)

Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients
por: Tokuda, Haruhiko, et al.
Publicado: (2015)

Leg lymphedema caused by iliopectineal bursitis associated with destruction of a rheumatoid hip joint: A case report
por: KUROYANAGI, GEN, et al.
Publicado: (2013)

Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2
por: Matsushima-Nishiwaki, Rie, et al.
Publicado: (2018)

Synergy by Ristocetin and CXCL12 in Human Platelet Activation: Divergent Regulation by Rho/Rho-Kinase and Rac
por: Enomoto, Yukiko, et al.
Publicado: (2023)

Thrombopoietin and collagen in low doses cooperatively induce human platelet activation
por: Doi, Tomoaki, et al.
Publicado: (2022)

Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells
por: Tanabe, Kumiko, et al.
Publicado: (2010)

Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation
por: Nakashima, Daiki, et al.
Publicado: (2020)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

HSP70 and HSP90 Differentially Regulate Translocation of Extracellular Antigen to the Cytosol for Cross-Presentation
por: Kato, Yu, et al.
Publicado: (2012)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

Heat shock protein 70 positively regulates transforming growth factor-α-induced hepatocellular carcinoma cell migration via the AKT signaling pathway
por: Kobayashi, Kaido, et al.
Publicado: (2020)

SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway
por: Matsushima-Nishiwaki, Rie, et al.
Publicado: (2022)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017)

The structure of FKBP38 in complex with the MEEVD tetratricopeptide binding-motif of Hsp90
por: Blundell, Katie L. I. M., et al.
Publicado: (2017)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Hsp40s Specify Functions of Hsp104 and Hsp90 Protein Chaperone Machines
por: Reidy, Michael, et al.
Publicado: (2014)

Control of Canalization and Evolvability by Hsp90
por: Milton, Claire C., et al.
Publicado: (2006)

Targeting HSP90 for cancer therapy
por: Mahalingam, D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3d54mgndhub24qqv26vmrrr8rf